Delivery Order SPE2DB20D1004-SPE2DB24FG0E0
Award Date 5/13/24
Potential Completion Date 6/4/24
Potential Value $5.6K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of VARIVAX vaccine with diluents to the Defense Logistics Agency (DLA) Troop Support Medical program. The firm fixed price delivery order, valued at $1,911.94, has an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of VARIVAX vaccine with diluents to the Defense Logistics Agency (DLA) for a total ceiling value of $4,685.05. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, is for the delivery of the VARIVAX vaccine with diluents to the Defense Logistics Agency (DLA). The contract has a ceiling value of $7,647.84 and an ultimate completion date of May 22, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation, is for the supply of VARIVAX vaccine with diluents to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $46,850.50, is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA. The IDC, valued up to $999,999,999.00 through December 31, 2025, serves as the primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, is for the delivery of VARIVAX vaccine with diluents. The contract has a ceiling value of $4,779.85 and a completion date of May 8, 2024. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of the VARIVAX vaccine with diluents to the Defense Logistics Agency (DLA). The award is a delivery order with a firm fixed price of $9,559.70 and an ultimate completion date of May 28, 2024. Amerisourcebergen, a major pharmaceutical distribution company, leverages its extensive supply chain to fulfill government contracts, particularly for the Department of Defense (DoD) and Department of...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $11,629.68, is for the delivery of the VARIVAX vaccine with diluents. The contract has a firm fixed price and an ultimate completion date of December 23, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of VARIVAX vaccines with diluents to the Defense Logistics Agency (DLA). The contract, valued at $93,701.00, is a Firm Fixed Price Delivery Order with a completion date of July 19, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31,...
- This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division, is for the delivery of Varivax vaccine with diluents to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $2,867.91 and is a firm fixed price delivery order with an ultimate completion date of April 25, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of VARIVAX vaccine with diluents. The firm-fixed-price Delivery Order, valued at $2,064.22, has an ultimate completion date of April 29, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB24FG0E0Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of VARIVAX vaccine with diluents to the Defense Logistics Agency (DLA). The contract, valued at $5,622.06, has a completion date of June 4, 2024 and was awarded on May 13, 2024. Amerisourcebergen has a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract award is not designated as a set-aside.
Generated 8/12/24, 9:26 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 5/13/24 |